Outcome in borderline disorders - A review of short-term, intermediate and long-term follow-up perspectives;Der verlauf von borderline-storungen: Eine literaturubersicht

Fortschritte der Neurologie Psychiatrie

Volumn 67, Issue 5, 1999, Pages 200-217

  Rothenhausler H B ^a   Kapfhammer, H P ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

AFFECTIVE NEUROSIS; AGGRESSION; ALCOHOLICS ANONYMOUS; ANTISOCIAL BEHAVIOR; ARTICLE; BEHAVIOR THERAPY; BORDERLINE STATE; CONTROLLED STUDY; DEPRESSION; FOLLOW UP; HOSTILITY; HUMAN; IMPULSIVENESS; INTELLIGENCE QUOTIENT; PSYCHOTHERAPY; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDE; TREATMENT OUTCOME; PSYCHOLOGICAL ASPECT; REVIEW;

BORDERLINE PERSONALITY DISORDER; HUMANS;

EID: 0033125546     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993997     Document Type: Article

References (121)

1. Akiskal, H. S.: Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm. Psychiatr. Clin. North. Am. 4 (1981) 25-46
2. Akiskal, H. S., S. E. Chen, Davius, G.C. et al.: Borderline: An adjective in search of a noun. J. Clin. Psychiatry 46 (1985) 41-48
3. American Psychiatric Association, Committee on Nomenclature and Statistics: DSM-III. APA. Washington DC (1980)
4. rd edn., revised. Am. Psychiatric Press. Washington DC (1987)
5. th edn. Am. Psychiatric Press. Washington DC (1994)
6. Antikainen, R., J. Hintikka, J. Lehtonen, H. Koponen, A. Arstilla.: A prospective three-year follow-up study of borderline personality disorder inpatients. Acta. Psychiatr. Scand. 92 (1995) 327-335
7. Barasch, A., A. Frances, S. Hurt, J. Clarkin, S. Cohen: Stability and distinctness of borderline personality disorder. Am. J. Psychiatry 142 (1985) 1484-1486
8. Beck, A. T., A. Freeman: Cognitive therapy of personality disorders. Guilford New York (1990)
9. Bleuler, E.: Dementia praecox oder Gruppe der Schizophrenien. Deuticke, Leipzig, Wien (1911)
10. Carpenter, W.T., J. G. Gunderson: Five Year Follow-up Comparison of Borderline and Schizophrenic Patients. Compr. Psychiatry 18 (1977) 567-571
11. Clare, A.W., V. E. Cairns: Design, development, and use of a standardized interview to assess social maladjustment and dysfunction in community studies. Psychol. Med. 8 (1978) 589-604
12. Clarkin, J. F., H. W. Koenigsberg, F. Yeomans et al.: Psychodynamic psychotherapy of the borderline patient. In: Clarkin. J. F., E. Marziali, H. Bloom (Eds): Borderline personality disorder: Clinical and Empirical Perspectives. Guilford, New York (1992) 268-287
13. Coccaro, E.F., L. J. Siever: The neuropharmacology of personality disorders. In: Bloom. F. E., D. J. Kupfer (Eds): Psychopharmacology: The fourth generation of progress. Raven Press, New York (1995) 1567-1579
14. Cowdry, R., D. L. Gardner: Pharmacotherapy of borderline personality disorder. Arch. Gen. Psychiatry 45 (1988) 111-119
15. Dahl, A. A.: A Critical Examination of Empirical Studies of the Diagnosis of Borderline Disorders in Adults. Psychiatric Developments 3 (1985) 1-29
16. Dahl, A. A.: Prognosis of the Borderline Disorders. Psychopathology 19 (1986) 68-79
17. Davis, G.C., H. S. Akiskal: Descriptive, biological and theoretical aspects of borderline personality disorder. Hosp. Comm. Psychiatry 37 (1986) 685-692
18. Derogatis, L. R., R. S. Lipman, L. Covi: SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol. Bull. 9 (1973) 13-28
19. Deutsch, H.: Über einen Typus der Pseudoaffektivität ("als ob"). Internationale Zeitschrift der Psychoanalyse 20 (1934) 323-335
20. Deutsch, H.: Some forms of emotional disturbance and their relationship to schizophrenia. Psychoanal. Q 11 (1942) 301-321
21. Endicott, J., R. L. Spitzer, J. L. Fleiss, J. Cohen: The Global Assessment Scale. Arch. Gen. Psychiatry 33 (1976) 766-771
22. Fiedler, P.: Borderline-Persönlichkeitsstörung. In: Fiedler P.: Persönlichkeitsstörungen. Beltz. Weinheim (1995) 215-237
23. Frankenburg, F. R., M. C. Zanarini: Clozapine treatment of borderline patients: a preliminary study. Compr. Psychiatry 34 (1993) 402-405
24. Frommer, J., V. Reißer: Neuere Ansätze zum Verständnis der Borderline-Persönlichkeitsstörung. Fortschr. Neurol. Psychiat. 65 (1997) 34-40
25. Gitlin, M. J.: Pharmacotherapy of personality disorders: Conceptual framework and clinical strategies. Journal of Clinical Psychopharmacology 13 (1993) 343-353
26. Goldberg, S. C., S. C. Schulz, R. J. Resnick, R. M. Hamer, R. O. Friedel: Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch. Gen. Psychiatry 43 (1986) 680-886
27. Grinker, R. R., B. Werble, R. C. Dryer: The borderline syndrome. A behavioral study of ego-functions. Basic Books. New York (1968)
28. Gunderson, J.G., M. T. Singer: Defining borderline patients: an overview. Am. J. Psychiatry 132 (1975) 1-10
29. Gunderson, J. G., W. T. Carpenter, J. S. Strauss: Borderline and schizophrenic patients: a comparative study. Am. J. Psychiatry 132 (1975) 1257-1264
30. Gunderson, J. G., J. E. Kolb: Discriminating features of borderline patients. Am. J. Psychiatry 135 (1978) 792-796
31. Gunderson, J. G., J. Kolb, V. Austin: The Diagnostic Interview for Borderline Patients. Am. J. Psychiatry 138 (1981) 896-903
32. Gunderson, J. G., M. C. Zanarini: Current overview of the borderline diagnosis. Clin. Psychiatry 48 (1987) 5-10
33. Guze, S. B., E. Robins: Suicide and primary affective disorders. Br. J. Psychiatry 117 (1970) 437-438
34. Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
35. Hamilton, M.: The rating of clinical anxiety. Br. J. Med. Psychol 32 (1959) 30-55
36. Hirschfeld, R. M. A.: Pharmacotherapy of borderline personality disorder. J. Clin. Psychiatry 58 (1997) 48-53
37. Hoch, P. H., P. Polatin: Pseudoneurotic forms of schizophrenia. Psychiatr Q 23 (1949) 248-276
38. Hoch, P.H., J. P. Cattell, M. O. Strahl, H. H. Pennes: The course and outcome of pseudoneurotic schizophrenia. Am. J. Psychiatry 119 (1962) 106-115
39. Hollingshead, A. B., F. C. Redlich: Social class and mental illness. Wiley, New York (1958)
40. Holm, K., E. Hundevadt: Psykiatrisk pasient. Episode eller livs-form? Tidsskrift for Den Norske Laegeforening 96 (1976) 1131-1135
41. Kapfhammer, H. P., P. Dobmeier: Psychodynamische, verhaltens-therapeutische und pharmakotherapeutische Ansätze in der Behandlung von Patienten mit Borderline-Persönlichkeitsstörungen. In: Möller, H.-J., H.-P. Kapfhammer (Hrsg): Interaktion von medikamentöser und psychosozialer Therapie in der Psychiatrie. Kuratorium für Forum Psychiatrie. Linz: Ed. Pro. Mente. (1996) 99-131
42. Kapfhammer, H. P: Pharmakotherapie bei Persönlichkeitsstörungen. In: Möller, H.-J. (Hrsg): Therapie psychiatrischer Erkrankungen. Enke, Stuttgart (1998) (im Druck)
43. Karterud, S., S. Vaglum, S. Friis, T. Irion, S. Johns, P. Vaglum: Day hospital therapeutic community treatment for patients with personality disorders.J. Nerv. Ment. Dis. 180 (1992) 238-243
44. Kernberg, O. F.: Borderline personality organization. J. Am. Psychoanal. Assoc.15 (1967) 641-685
45. Kernberg, O. F.: Borderline conditions and pathological narcissism. Jason Aronson Inc. New York (1975)
46. Kernberg, O.F.: The structural diagnosis of borderline personality organization. In: Hartocollis, P. (Ed.). Borderline personality disorders: the concept, the syndrome, the patient. International University Press. New York (1978)
47. Kernberg, O. F.: Structural Interviewing. Psychiat. Clin. North Amer.4 (1981) 169-195
48. Kernberg, O. F., E. G. Goldstein, A. C. Carr, H. F. Hunt, S. F. Bauer, R. Blumenthal: Diagnosing Borderline Personality. A Pilot Study Using Multiple Diagnostic Methods. J. Nerv. Ment. Dis. 169 (1981) 225-231
49. Kety, S. S., D. Rosenthal, P. H. Wender, F. Schulsinger: The types and prevalences of mental illness in the biological and adoptive families of adopted schizophrenics. In: Rosenthal, D. S., S. S. Kety (Eds): The transmission of schizophrenia. Pergamon. New York (1968) 73-82
50. Knight, R. P.: Borderline states. Bull. Menninger Clin. 17 (1953) 1-12
51. Koenigsberg, H. W.: The combination of psychotherapy and pharmacotherapy in the treatment of borderline patients. Journal of Psychotherapy in Practice and Research 3 (1994) 93-107
52. Kroll, J., L. Sines, K. Martin, S. Lari, R. Pyle, J. Zander: Borderline Personality Disorder. Construct Validity of the Concept. Arch. Gen. Psychiatry 38 (1981) 1021-1026
53. Kroll, J. L., K. S. Carey, L. K. Sines: Twenty Year Follow-up of Borderline Personality Disorder: A Pilot Study. In: Shagass, C., R. C. Josiassen, W. H. Bridger, K. J. Weiss, D. Stoff, G. M. Simpson (Eds.). Proceedings of the IVth World Congress of Biological Psychiatry. Elsevier. New York. Amsterdam. London (1985) 577-579
54. Leone, N. F.: Response of borderline patients to loxapine and chlorpromazine, J. Clin. Psychiatry 43 (1982) 148-150
55. Liebowitz, M. R., D. G. Klein: Inter-relationship of hysteroid dysphoria and borderline personality disorder. Psychiatric Clin. North Am. 4 (1981) 67-87
56. Linehan, M. M.: Dialectic behavior therapy for borderline personality disorder: Theory and method. Bulletin of the Menninger Clinic 51 (1987) 261-276
57. Linehan, M. M., H. E. Armstrong, A. Suarez, D. Allmon, H. L. Heard: Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch. Gen. Psychiatry 48 (1991) 1060-1064
58. Linehan, M. M., H. L. Heard, H. E. Armstrong: Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch. Gen. Psychiatry 50 (1993) 971-974
59. Links, P. S., J. E. Mitton, M. Steiner: Predicting outcome for borderline personality disorder. Compr. Psychiatry 31 (1990) 490-498
60. Loranger, A.W., J. M. Oldham, L M. Russakoff, V. Susman: Structured interviews and borderline personality disorder. Arch. Gen. Psychiat. 41 (1984) 565-568
61. Luborsky, L.: Clinicians' judgments of mental health: A proposed scale. Arch. Gen. Psychiatry 7 (1962) 407-417
62. Markovitz, P. J., J. R. Calabrese, S. C. Schulz, H. Y. Meltzer: Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am. J. Psychiatry 148 (1991) 1064-1067
63. Markovitz, P. J., S. C. Wagner: Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol. Bull. 31 (1995) 773-777
64. Masterson, J., J. Costello: From borderline adolescent to functioning adult. Brunner/Mazel. New York (1980)
65. McGlashan, T. H.: The Chestnut Lodge follow-up study, I: Follow-up methodology and study sample. Arch. Gen. Psychiatry 41 (1984) 573-585
66. McGlashan, T. H.: The Chestnut Lodge Follow-up Study: III. Long-term Outcome of Borderline Personalities. Arch. Gen. Psychiatry 43 (1986a) 20-30
67. McGlashan, T. H.: Schizotypal Personality Disorder. Arch. Gen. Psychiatry 43 (1986b) 329-334
68. Mehlum, L., S. Friis, T. Irion, T. Johns, S. Karterud, P. Vaglum, S. Vaglum: Personality disorders 2-5 years, after treatment: a prospective follow-up study. Acta. Psychiatr. Scand. 84 (1991) 72-77
69. Mehlum, L., S. Friis, P. Vaglum, S. Karterud: The longitudinal pattern of suicidal behaviour in borderline personality disorder: a prospective follow-up study. Acta. Psychiatr. Scand. 90 (1994) 124-130
70. Modestin, J.: Über den Borderline. Fortschr. Neurol. Psychiat. 48 (1980) 140-163
71. Modestin, J., C. Villiger: Follow-up study on borderline versus nonborderline personality disorders. Compr. Psychiatry 30 (1989) 236-244
72. Montgomery, S. A., D. Montgomery: Pharmacological prevention of suicidal behaviour. J. Affect. Dis. 4 (1982) 291-298
73. Najavits, L. M., J. G. Gunderson: Better than expected: Improvements in borderline personality disorder in a 3-year prospective outcome study. Comprehensive Psychiatry 4 (1995) 296-302
74. Nyman, G. E.: The clinical picture of non-regressive schizophrenia. Nord. Psykiat. Tidskr. 29 (1975) 249-258
75. Nyman, A. K.: Non-Regressive Schizophrenia: Clinical Course and Outcome. Acta. Psychiatr. Scand. suppl. 272 (1978) 1-143
76. Paris J., R. Brown, D. Nowlis: Long-term Follow-up of Borderline Patients in a General Hospital. Compr. Psychiatry 28 (1987) 530-535
77. Paris, J.: Follow-up studies of borderline personality disorder: a critical review. J. Pers. Disord. 2 (1988) 189-197
78. Paris, J.: Outcome. In: Paris, J.: Borderline Personality Disorder. A multidimensional approach. American Psychiatric Press Washington DC (1994) 99-107
79. Perry, J. C.: Depression in Borderline Personality Disorder: Life-time Prevalence at Interview and Longitudinal Course of Symptoms. Am. J. Psychiatry 142 (1985) 15-21
80. Perry, J. C., S. H. Cooper: Psychodynamics, symptoms, and out come in borderline personality disorders and bipolar type II affective disorder. In: McGlashan, T. H. (Ed.). The Borderline: Current Empirical Research. American Psychiatric Press. Washington DC (1985)
81. Plakun, E.M., P. E. Burkhardt, J. P. Muller: 14-Year Follow-Up of Borderline and Schizotypal Personality Disorders. Compr. Psychiatry 26 (1985) 448-455
82. Pope, H. G., J. F. Lipinski, B. M. Cohen, D. T. Axelrod: "Schizoaffective disorder": An invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am. J. Psychiatry 137 (1980) 921-927
83. Pope, H.G., J. M. Jonas, J. I. Hudson, B. M. Cohen, J. G. Gunderson: The Validity of DSM-III Borderline Personality Disorder. A Phenomenologic, Family History, Treatment Response, and Long-term Follow-up Study. Arch. Gen. Psychiatry 40 (1983) 23-30
84. Rifkin, A., F. Quitkin, G. Carrillo et al.: Lithium carbonate in emotionally unstable character disorders. Arch. Gen. Psychiatry 27 (1972) 519-523
85. Rohde-Dachser, Ch.: Borderlinestörungen. In: Kisker, K. P., H. Lauter, J. E. Meyer, C. Müller, E. Strömgren (Hrsg.). Psychiatrie der Gegenwart, Bd. 1: Neurosen, Psychosomatische Erkrankungen, Psychotherapie. Springer. Berlin (1986) 125-150
86. Saß, H., K. Koehler: Borderline-Syndrom: Grenzgebiet oder Niemandsland? Zur klinisch-psychiatrischen Relevanz von Borderline-Diagnosen. Nervenarzt 54 (1983) 221-230
87. Senol, S., C. Dereboy, N. Yüksel: Borderline disorder in Turkey: a 2- to 4-year follow-up. Soc. Psychiatry Psychiatr. Epidemiol. 32 (1997) 109-112
88. Serban. G., S. Siegel: Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am. J. Psychiatry 141 (1984) 1455-1458
89. Sheard, M. H.: Effect of lithium on human aggression. Nature 230 (1971) 113-114
90. Sheard, M. H.: Lithium in the treatment of aggression. J. Nerv. Ment. Dis. 160 (1975) 108-118
91. Sheehy, M., L. Goldsmith, E. Charles: A comparative study of borderline patients in a psychiatric outpatient clinic. Am. J. Psychiatry 137 (1980) 1374-1379
92. Siever, L. J., K. L. Davis,: A psychobiological perspective on the personality disorder. Am. J. Psychiatry 148 (1991) 1647-1658
93. Skodol, A.E., P. Buckley, E. Charles: Is there a characteristic pattern to the treatment history of clinic outpatients with Borderline Personality? J. Nerv. Ment. Dis. 171 (1983) 405-410
94. Soloff, P. H., A. George, R. S. Nathan et al.: Progress in pharmacotherapy of borderline disorders: A double blind study of amitriptyline, haloperidol and placebo. Arch. Gen. Psychiatry 43 (1986) 691-697
95. Soloff, P. H., J. Cornelius, A. George, S. Nathan, M. Perel, R. F. Ulrich: Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch. Gen. Psychiatry 50 (1993) 377-385
96. Soloff, P. H.: Is there any drug treatment of choice for the borderline patient? Acta. Psychiatr. Scand. Suppl. 379 (1994) 50-55
97. Spitz, R. A.: Anaclitic depression. Psychoanalytic Study of the Child 2 (1946) 313-341
98. Spitzer, R. L., J. Endicott, M. Gibbon: Crossing the border into borderline personality and borderline schizophrenia: The development of criteria. Arch. Gen. Psychiatry 36 (1979) 17-24
99. Spitzer, R. L., J. B. Williams: Structured Clinical Interview for DSM-III-R. New York State Psychiatric Institute, Biometrics Research Department. New York (1985)
100. Stein, D. J., D. Simeon, M. Frenkel, M. N. Islam, E. Hollander: An open trial of valproate in borderline personality disorder. J. Clin. Psychiatry 56 (1995) 506-510
101. Stein, G.: Drug treatment of the personality disorders. Br. J. Psychiatry 161 (1992) 167-184
102. Stern, A.: Psychoanalytic investigation of an therapy in the borderline group of neuroses. Psychoanal. Q 7 (1938) 467-489
103. Stevenson, J., R. Meares: An outcome study of psychotherapy for patients with borderline personality disorder. Am. J. Psychiatry 149 (1992) 358-362
104. Stone, M. H.: The Borderline Syndromes: Constitution, adaptation and personality. McGraw-Hill Books Co. New York (1980)
105. Stone M. H., W. H. Stephen, D. K. Stone: The PI 500: Long-Term Follow-up of Borderline Inpatients Meeting DSM-III Criteria: I. Global Outcome. Journal of Personality Disorders 1 (1987a) 291-298 7
106. Stone, M. H., D. K. Stone, S. W. Hurt: Natural history of borderline patients treated by intensive hospitalization. Psychiatric Clinics of North America 10 (1987b) 185-2 06
107. Stone, M. H.: The course of borderline personality disorder. In: Tasman, A., R. E. Hales, A. J. Frances (Eds): Review of Psychiatry. American Psychiatric Press Vol. 8. Washington DC (1989) 103-122
108. Stone, M. H.: Borderline Personality Disorder: course of illness. In: Clarkin, John F., Elsa Marziali, Heather Munroe-Blum: Borderline Personality Disorder. Clinical and empirical perspectives. The Guilford Press. New York London (1992) 67-86
109. Stone, M. H.: Long-term outcome in personality disorders. In: Stone, M. H.: Abnormalities of Personality. W. W. Norton & Company. New York, London (1993) 131-152
110. Stone, M.: Langzeit-Katamnesen von leichten und schweren Persönlichkeitsstörungen - Therapeutische Implikationen. Psychotherapie 2 (1997) 29-36
111. Tolle, R.: The mastery of life by psychopathic personalities. Psychiatrica Clin. 1 (1968) 1-9
112. Tucker, L., S. F. Bauer, S. Wagner, D. Harlam, I. Sher: Long-term hospital treatment of borderline patients: a descriptive outcome study. Am. J. Psychiatry 144 (1987) 1443-1448
113. Waldinger, R. J., J. G. Gunderson: Completed psychotherapies with borderline patients. Am. J. Psychother. 38 (1984) 190-202
114. Wallerstein, R.: Forty-two lives in treatment. Guilford Press. New York (1986)
115. Weltgesundheitsorganisation - WHO: Klassifikation psychischer Krankheiten. Klinisch-diagnostische Leitlinien nach Kapitel V (F) der ICD-10 (2. Überarbeitete und erweiterte Aufl.; Hrsg.: Dilling, H., W. Mombour, M. H. Schmidt). Huber. Bern (1993)
116. Weltgesundheitsorganisation - WHO: Klassifikation psychischer Krankheiten. Forschungskriterien nach Kapitel V (F) der ICD-10 (1.Aufl.; Hrsg.: Dilling. H., W. Mombour, M. H. Schmidt). Huber. Bern (1994)
117. Werble, B.: Second Follow-up Study of Borderline Patients. Arch. Gen. Psychiatry 23 (1970) 3-7
118. Wilkinson, D. G.: The suicide rate in schizophrenia. Br. J. Psychiatry 140 (1982) 138-141
119. Woollcott, P.: Prognostic indicators in the psychotherapy of borderline patients. Am. J. Psychother. (1985) 17-29
120. World Health Organization: The International Pilot Study of Schizophrenia. WHO. Geneva Vol. 1, (1973)
121. Zanarini, M.C., D. L. Chauncey, R. A. Grady, J. G. Gunderson: Out-come studies of borderline personality disorder. In: Mirin, S. M., J. T. Gossett, M. C. Grob (Eds): Psychiatric Treatment. Advances in Outcome Research. American Psychiatric Press. Washington DC (1991)